The COX2-PGE2-PKA Axis Suppresses Antiviral Immunity by Inhibiting mtDNA-Dependent STING Activation.

This study reveals that the COX2/PGE2/PKA axis suppresses antiviral immunity by inducing STOML2-mediated mitophagy to clear cytosolic mitochondrial DNA, thereby inhibiting STING activation and the subsequent type I interferon response during HSV-1 infection.

The Gist

The Big Picture: A Security System with a "Silence" Button

Imagine your body is a high-tech fortress. Inside this fortress, there is a super-sensitive intruder alarm system called STING. Its job is to detect when the enemy (viruses) breaks in or when the fortress's own internal machinery (mitochondria) starts breaking down and leaking dangerous signals.

When the alarm goes off, it triggers a massive defense team (Type I Interferons) to fight off the virus. This is usually a good thing. However, this specific paper discovered a sneaky "saboteur" that the virus uses to turn off the alarm before the defense team can fully mobilize.

That saboteur is a molecule called PGE2 (Prostaglandin E2).

Here is the step-by-step story of how this works, explained like a heist movie.

---

1. The Break-In (The Virus Attack)

When the Herpes Simplex Virus (HSV-1) attacks a cell, it doesn't just bring its own weapons; it also sabotages the cell's power plants (the mitochondria).

• The Sabotage: The virus destroys a protein called TFAM, which acts like the "manager" keeping the mitochondrial DNA (mtDNA) organized.
• The Leak: Without the manager, the mitochondrial DNA spills out of the power plant and into the main hall of the cell (the cytosol).
• The Alarm: The STING alarm system sees this spilled DNA and thinks, "Intruder! Or at least, something is very wrong!" It sounds the siren and calls the immune defense team.

2. The Saboteur Arrives (PGE2)

Here is where the virus gets clever. As the alarm starts to ring, the cell (and the virus) accidentally produces a chemical called PGE2.

• The Analogy: Think of PGE2 as a "Silence Button" or a "Mute Switch" for the alarm.
• The Effect: Instead of letting the alarm ring loud and clear, PGE2 tells the cell, "Hey, calm down, everything is fine." It stops the immune system from fighting the virus effectively, allowing the virus to replicate and spread.

3. How the Silence Button Works (The Mechanism)

The paper explains exactly how PGE2 hits that mute button. It's a chain reaction, like a row of dominoes:

1. The Signal: PGE2 knocks on the door of a specific receptor called EP4.
2. The Messenger: This knocks over a domino called cAMP, which wakes up a worker named PKA (Protein Kinase A).
3. The Worker's Task: PKA is a "foreman." Its job is to find a specific protein called STOML2 and give it a "high-five" (a chemical tag called phosphorylation) at a specific spot (Serine 29).
4. The Cleanup Crew: Once STOML2 gets that high-five, it activates a cleanup crew called PINK1.
5. The Cleanup (Mitophagy): PINK1's job is mitophagy (literally "eating mitochondria"). It hunts down the broken, damaged mitochondria that are leaking DNA and sends them to the cell's trash compactor (the lysosome) to be destroyed.

The Result: By cleaning up the broken mitochondria before they leak too much DNA, the cell removes the fuel for the alarm. No leaked DNA = No alarm = No immune defense. The virus wins.

4. The Twist: A Feedback Loop

The most interesting part of this discovery is that this isn't just a virus trick; it's a natural safety valve that got hijacked.

• When the alarm (STING) goes off, the cell naturally produces PGE2 to calm things down so the immune system doesn't overreact and damage the body itself.
• The Problem: The virus exploits this natural "calm down" signal to shut down the defense completely. It's like a burglar who knows the house has a "Do Not Disturb" sign and uses it to hide while stealing the TV.

5. The Solution (The Takeaway)

The researchers found that if you block this "Silence Button" (by stopping PGE2, blocking the EP4 receptor, or stopping the PKA worker), the alarm stays loud.

• The Outcome: The immune system wakes up, sees the virus, and clears it out much faster.
• The Future: This suggests that drugs which block this specific pathway (COX2/PGE2/PKA) could be used to boost the body's natural ability to fight viral infections and potentially even cancer, by keeping the STING alarm ringing loud and clear.

Summary in One Sentence

The virus tricks the body into cleaning up its own broken parts (mitochondria) to hide the evidence of the attack, effectively turning off the immune alarm; but if we stop this cleaning process, the alarm rings, and the body wins the fight.

Technical Summary

1. Problem Statement

The innate immune system relies on the cGAS-STING pathway to detect cytosolic double-stranded DNA (dsDNA) from pathogens or host damage, triggering a Type I Interferon (IFN) response essential for antiviral defense. However, viral infections often evade complete clearance, suggesting the existence of regulatory mechanisms that dampen STING signaling.

• The Gap: While Prostaglandin E2 (PGE2) is known to suppress adaptive immunity (T cells, NK cells), its specific role in regulating innate immunity and the cGAS-STING pathway during viral infection remains unclear.
• The Hypothesis: The authors investigate whether the inflammatory mediator PGE2, produced by Cyclooxygenase-2 (COX2), acts as a negative feedback regulator of STING-mediated antiviral responses, potentially exploiting mitochondrial DNA (mtDNA) leakage as a trigger.

2. Methodology

The study employed a multidisciplinary approach combining virology, immunology, proteomics, and advanced imaging:

• Cell Models: Murine bone marrow-derived macrophages (BMDMs) and human THP-1 derived macrophages were used as primary models. HEK293 cells were used for overexpression and reporter assays.
• Viral Infection: Cells were infected with Herpes Simplex Virus 1 (HSV-1), a model for STING-dependent antiviral immunity.
• Pharmacological & Genetic Manipulation:
  • Treatment with PGE2, COX2 inhibitors (Celecoxib), EP4 antagonists, and PKA inhibitors.
  • siRNA knockdown of TFAM (to induce mtDNA release), PINK1, and STOML2.
  • Use of ddC (dideoxycytidine) to inhibit mtDNA replication.
• Omics & Proteomics:
  • Bulk RNA-seq: To analyze transcriptional changes in HSV-1 infected macrophages with/without PGE2.
  • Affinity Purification-Mass Spectrometry (AP-MS): To identify interactors of the PKA catalytic subunit (PKA Cα), utilizing a wild-type and a regulatory-subunit-deficient mutant (W197R) to capture the full interactome.
• Advanced Imaging:
  • Airyscan Live-Cell Imaging: Using PicoGreen (DNA) and MitoTracker to visualize cytosolic mtDNA leakage.
  • mt-mKeima Sensor: A pH-sensitive fluorescent protein fused to mitochondria to quantify mitophagy flux (shift from neutral cytosol to acidic lysosome).
  • 4D Lattice Light-Sheet Microscopy: To track the speed and displacement of mitolysosomes in real-time.
• Molecular Biology: Western blotting for phosphorylation events (TBK1, IRF3, Ubiquitin, STOML2), qPCR for viral load and ISG expression, and ELISA for cytokine secretion (IFN-β, PGE2).

3. Key Contributions & Mechanistic Findings

A. PGE2 Suppresses Antiviral Immunity via the COX2/PGE2 Axis

• Observation: PGE2 treatment significantly increased HSV-1 replication and reduced viral clearance in macrophages.
• Mechanism: PGE2 suppressed the transcription of Type I Interferon Stimulated Genes (ISGs) and IFN-β secretion. RNA-seq revealed that PGE2 specifically downregulated pathways related to the "Interferon Alpha/Beta Response" and "Defense Response to Virus."
• Feedback Loop: HSV-1 infection itself upregulates COX2 and PGE2 production, establishing an autocrine negative feedback loop that restrains the immune response.

B. Specific Inhibition of mtDNA-Dependent STING Activation

• Differentiation: PGE2 did not inhibit STING activation triggered by synthetic cGAMP or viral DNA directly. Instead, it specifically blocked STING activation triggered by cytosolic mitochondrial DNA (mtDNA).
• Viral Induction of mtDNA Leakage: HSV-1 infection depletes TFAM (a mitochondrial nucleoid protein), leading to the release of mtDNA into the cytosol. This mtDNA is a critical trigger for the antiviral response.
• Evidence: Inhibiting mtDNA replication (via ddC) or depleting TFAM reduced IFN responses, confirming mtDNA's role. PGE2 treatment reversed the immune activation caused by TFAM depletion.

C. The EP4-cAMP-PKA Signaling Axis

• Pathway: PGE2 signals through the EP4 receptor, leading to increased intracellular cAMP and activation of Protein Kinase A (PKA).
• Validation: Pharmacological inhibition of EP4 or PKA abolished the suppressive effects of PGE2, restoring IFN-β production and reducing viral load.

D. Discovery of STOML2 as the Critical Effector

• Proteomics: AP-MS identified STOML2 (Stomatin-like protein 2) as a novel PKA interactor.
• Phosphorylation: PKA phosphorylates STOML2 at Serine 29 (Ser29). This was confirmed via mutagenesis (S29A mutant) and phospho-specific antibodies.
• Function: Phosphorylated STOML2 stabilizes PINK1, a key kinase required for the initiation of mitophagy.
• Consequence: PGE2-PKA signaling enhances PINK1-mediated mitophagy. This process efficiently removes damaged mitochondria before they can release immunostimulatory mtDNA into the cytosol.

E. Mitophagy as an Immune Evasion Strategy

• Outcome: By promoting mitophagy, PGE2 reduces the pool of cytosolic mtDNA available to activate cGAS.
• Rescue: Depletion of PINK1 or STOML2 (or mutation of STOML2 Ser29) prevented PGE2 from suppressing the immune response, proving that mitophagy is the mechanism of immune evasion.
• Homeostasis: The study notes that PGE2 also upregulates PGC-1α (mitochondrial biogenesis), suggesting a coordinated effort to replace cleared mitochondria, maintaining cellular health while suppressing inflammation.

4. Results Summary

1. PGE2 promotes HSV-1 replication by suppressing Type I IFN responses.
2. COX2/PGE2 is upregulated during HSV-1 infection, forming a negative feedback loop.
3. PGE2 specifically inhibits mtDNA-STING signaling, not viral DNA-STING signaling.
4. PGE2 activates the EP4-cAMP-PKA axis, which phosphorylates STOML2 at Ser29.
5. Phosphorylated STOML2 stabilizes PINK1, driving mitophagy.
6. Enhanced mitophagy clears damaged mitochondria, preventing mtDNA leakage and subsequent cGAS-STING activation.
7. Blocking this axis (via COX2 inhibitors, EP4 antagonists, or PKA inhibitors) restores antiviral immunity.

5. Significance

• Novel Immune Evasion Mechanism: The paper identifies a sophisticated viral strategy where the host's own inflammatory mediator (PGE2) is co-opted to suppress innate immunity by enhancing mitochondrial quality control (mitophagy) to hide the "danger signal" (mtDNA).
• Therapeutic Potential: The findings suggest that COX2 inhibitors (like Celecoxib) or EP4/PKA antagonists could be repurposed as adjuvants to boost STING-mediated antiviral immunity and potentially enhance cancer immunotherapy (where STING activation is also desired).
• Broader Implications: This mechanism links mitochondrial quality control directly to innate immune regulation. It suggests that dysregulation of the COX2-PGE2-PKA axis may contribute to chronic inflammation, aging, and neurodegeneration where mtDNA-STING signaling is implicated.
• Molecular Insight: The identification of STOML2 as a PKA substrate and a molecular hub connecting GPCR signaling to mitochondrial dynamics provides a new target for modulating cellular stress responses.

In conclusion, the study establishes that the COX2-PGE2-PKA-STOML2 axis acts as a "brake" on antiviral immunity by clearing the mitochondrial triggers (mtDNA) required to activate the cGAS-STING pathway.